These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12210070)

  • 41. Deletion mapping of 18q in conventional renal cell carcinoma.
    Hirata H; Matsuyama H; Matsumoto H; Korenaga Y; Ohmi C; Sakano S; Yoshihiro S; Naito K
    Cancer Genet Cytogenet; 2005 Dec; 163(2):101-5. PubMed ID: 16337851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multifocal renal cell carcinoma: evidence for a common clonal origin.
    Miyake H; Nakamura H; Hara I; Gohji K; Arakawa S; Kamidono S; Saya H
    Clin Cancer Res; 1998 Oct; 4(10):2491-4. PubMed ID: 9796982
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chromosome 14q may harbor multiple tumor suppressor genes in primary glioblastoma multiforme.
    Hu J; Jiang C; Ng HK; Pang JC; Tong CY
    Chin Med J (Engl); 2002 Aug; 115(8):1201-4. PubMed ID: 12215292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival.
    Ragnarsson G; Eiriksdottir G; Johannsdottir JT; Jonasson JG; Egilsson V; Ingvarsson S
    Br J Cancer; 1999 Mar; 79(9-10):1468-74. PubMed ID: 10188892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Organ-confined clear cell renal cell carcinoma: the prognostic impact of microvascular invasion, nuclear grade and tumour size.
    Zubac DP; Bostad L; Kihl B; Eide J; Wentzel-Larsen T; Haukaas SA
    APMIS; 2008 Dec; 116(12):1027-33. PubMed ID: 19133004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distal nephron renal tumors: microsatellite allelotype.
    Polascik TJ; Cairns P; Epstein JI; Fuzesi L; Ro JY; Marshall FF; Sidransky D; Schoenberg M
    Cancer Res; 1996 Apr; 56(8):1892-5. PubMed ID: 8620510
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Allelic losses at chromosomes 1p, 2p, 6p, 10p, 13q, 17p, and 21q significantly correlate with the chromophobe subtype of renal cell carcinoma.
    Schwerdtle RF; Störkel S; Neuhaus C; Brauch H; Weidt E; Brenner W; Hohenfellner R; Huber C; Decker HJ
    Cancer Res; 1996 Jul; 56(13):2927-30. PubMed ID: 8674042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumour suppressor gene (CDKNA2) status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer.
    El-Mokadem I; Kidd T; Pratt N; Fleming S; Nabi G
    Oncotarget; 2016 Nov; 7(45):73045-73054. PubMed ID: 27682877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
    Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
    Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of minimal regions of deletion at 8p23.1-22 associated with metastasis of hepatocellular carcinoma.
    Lu T; Hano H
    Liver Int; 2007 Aug; 27(6):782-90. PubMed ID: 17617121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of heterozygosity of chromosome 1q in gastrinomas: occurrence and prognostic significance.
    Chen YJ; Vortmeyer A; Zhuang Z; Huang S; Jensen RT
    Cancer Res; 2003 Feb; 63(4):817-23. PubMed ID: 12591732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concentration and microsatellite status of plasma DNA for monitoring patients with renal carcinoma.
    Perego RA; Corizzato M; Brambilla P; Ferrero S; Bianchi C; Fasoli E; Signorini S; Torsello B; Invernizzi L; Bombelli S; Angeloni V; Pitto M; Battaglia C; Proserpio V; Magni F; Galasso G; Mocarelli P
    Eur J Cancer; 2008 May; 44(7):1039-47. PubMed ID: 18397824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic implications for gastric carcinoma based on loss of heterozygosity genotypes correlation with clinicopathologic variables.
    Koo SH; Jeong TE; Kang J; Kwon KC; Park JW; Noh SM
    Cancer Genet Cytogenet; 2004 Aug; 153(1):26-31. PubMed ID: 15325090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy.
    Kozlowski L; Filipowski T; Rucinska M; Pepinski W; Janica J; Skawronska M; Poznanski J; Wojtukiewicz MZ
    Neoplasma; 2006; 53(5):440-3. PubMed ID: 17013540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High frequency of allelic losses in high-grade prostate cancer is associated with biochemical progression after radical prostatectomy.
    Valeri A; Fromont G; Sakr W; Azzouzi R; Dey J; Chantrel-Groussard K; Latil A; Berthon P; Cussenot O; Pontes JE; Cher ML
    Urol Oncol; 2005; 23(2):87-92. PubMed ID: 15869992
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma.
    Obermann EC; Diss TC; Hamoudi RA; Munson P; Wilkins BS; Camozzi ML; Isaacson PG; Du MQ; Dogan A
    J Pathol; 2004 Feb; 202(2):252-62. PubMed ID: 14743509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
    Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of matrix metalloproteinase-10 in renal cell carcinoma and its prognostic role.
    Miyata Y; Iwata T; Maruta S; Kanda S; Nishikido M; Koga S; Kanetake H
    Eur Urol; 2007 Sep; 52(3):791-7. PubMed ID: 17207914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss of heterozygosity at the FHIT gene in different solid human tumours and its association with survival in colorectal cancer patients.
    Petursdottir TE; Hafsteinsdottir SH; Jonasson JG; Moller PH; Thorsteinsdottir U; Huiping C; Egilsson V; Ingvarsson S
    Anticancer Res; 2002; 22(6A):3205-12. PubMed ID: 12530066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.